Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
rare diseases
Biotech
FDA chides Applied Therapeutics' trial conduct in warning letter
While Applied Therapeutics plans to appeal a recent rejection of govorestat, issues with the biotech’s clinical conduct could hamper those plans.
Fraiser Kansteiner
Dec 4, 2024 11:21am
FDA rejects Applied filing for rare disease approval
Dec 2, 2024 5:27am
Plant compound restores sensation in mice with nerve disorder
Nov 20, 2024 2:30pm
AI data platform builder Citizen Health raises $14.5M
Nov 19, 2024 7:00am
Amgen disappears lung disease program after phase 2 fail
Oct 30, 2024 5:59pm
GemVax's peptide drug fails phase 2a neurodegenerative trial
Oct 29, 2024 11:28am
